» Articles » PMID: 39007986

"I Heard of PrEP-I Didn't Think I Needed It." Understanding the Formation of HIV Risk Perception Among People Who Inject Drugs

Overview
Specialty Social Sciences
Date 2024 Jul 15
PMID 39007986
Authors
Affiliations
Soon will be listed here.
Abstract

Uptake of pre-exposure prophylaxis medication (PrEP) to prevent HIV among people who inject drugs (PWID) remains extremely low in the United States. West Virginia's rising HIV incidence and highest drug overdose rate in the nation makes it an important locus for opioid use and HIV risk interaction. In this pilot study we pioneered the use of Cultural Theory among PWID to understand HIV-related risk perception arising from four contrasting modes of social organization. Carried out during an HIV outbreak, we explored PrEP uptake qualitatively as a window onto risk perception. Of the 26 interviewees, 18 were HIV- and despite the medication's free availability from the health center where recruitment took place, none had taken PrEP, half considering they were not at risk. Intimate couples who showed characteristics of 'enclaves' considered the boundary around themselves protective against HIV, creating a safe space or 'invisible risk group'. Higher HIV risk was perceived among those who were housed compared to those living homeless. Beliefs about the causation of the local HIV outbreak and the validity of scientific research corresponded with characteristics of the contrasting modes of social organization and the approach is promising for informing public health interventions among PWID.

References
1.
Helman C . "Feed a cold, starve a fever"--folk models of infection in an English suburban community, and their relation to medical treatment. Cult Med Psychiatry. 1978; 2(2):107-37. DOI: 10.1007/BF00054580. View

2.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

3.
Garner W, Wilson B, Beste L, Maier M, Ohl M, Van Epps P . Gaps in Preexposure Prophylaxis Uptake for HIV Prevention in the Veterans Health Administration. Am J Public Health. 2018; 108(S4):S305-S310. PMC: 6215372. DOI: 10.2105/AJPH.2018.304788. View

4.
Dahlby L, Boyd J, Knight R, Philbin M, Small W, Kerr T . The perspectives of street-involved youth who use drugs regarding the acceptability and feasibility of HIV pre-exposure prophylaxis: a qualitative study. AIDS Care. 2022; 35(4):480-487. PMC: 9930182. DOI: 10.1080/09540121.2022.2085868. View

5.
Biello K, Bazzi A, Mimiaga M, Biancarelli D, Edeza A, Salhaney P . Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018; 15(1):55. PMC: 6233595. DOI: 10.1186/s12954-018-0263-5. View